NDC 0023-6501

UBRELVY

Ubrogepant

UBRELVY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Ubrogepant.

Product ID0023-6501_179b083b-faaf-4092-9f87-005dab651067
NDC0023-6501
Product TypeHuman Prescription Drug
Proprietary NameUBRELVY
Generic NameUbrogepant
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-12-23
Marketing CategoryNDA / NDA
Application NumberNDA211765
Labeler NameAllergan, Inc.
Substance NameUBROGEPANT
Active Ingredient Strength100 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0023-6501-10

10 PACKET in 1 BOX (0023-6501-10) > 1 TABLET in 1 PACKET (0023-6501-02)
Marketing Start Date2019-12-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0023-6501-02 [00023650102]

UBRELVY TABLET
Marketing CategoryNDA
Application NumberNDA211765
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-12-23

NDC 0023-6501-30 [00023650130]

UBRELVY TABLET
Marketing CategoryNDA
Application NumberNDA211765
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-23

NDC 0023-6501-08 [00023650108]

UBRELVY TABLET
Marketing CategoryNDA
Application NumberNDA211765
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-23

NDC 0023-6501-10 [00023650110]

UBRELVY TABLET
Marketing CategoryNDA
Application NumberNDA211765
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-12-23

NDC 0023-6501-12 [00023650112]

UBRELVY TABLET
Marketing CategoryNDA
Application NumberNDA211765
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-23

NDC 0023-6501-06 [00023650106]

UBRELVY TABLET
Marketing CategoryNDA
Application NumberNDA211765
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-23

Drug Details

Active Ingredients

IngredientStrength
UBROGEPANT100 mg/1

NDC Crossover Matching brand name "UBRELVY" or generic name "Ubrogepant"

NDCBrand NameGeneric Name
0023-6498UBRELVYubrogepant
0023-6501UBRELVYubrogepant

Trademark Results [UBRELVY]

Mark Image

Registration | Serial
Company
Trademark
Application Date
UBRELVY
UBRELVY
88185227 not registered Live/Pending
Allergan Pharmaceuticals International Limited
2018-11-07
UBRELVY
UBRELVY
88155130 not registered Live/Pending
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
2018-10-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.